Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review
DOI:
https://doi.org/10.33448/rsd-v10i11.19769Keywords:
Self-medication; Risk factors; COVID-19 pandemic; Pharmacists.Abstract
Although self-medication is a common practice, it can lead to several health problems, such as masking diseases, causing drug interactions, bacterial resistance and intoxication. During the COVID-19 pandemic many news articles were spread encouraging the use of drugs for the prevention and treatment of SARS-CoV-2, such as chloroquine, hydroxychloroquine, nitazoxanide, ivermectin, etc. However, there is no scientific proof of their efficacy for this purpose. The objective of the present study was to systematically review the existing literature on self-medication and relate it to the COVID-19 pandemic. A literature review search was performed and a total of 27 scientific articles were summarized and discussed. Self-medication as a result of panic, bad information, and the culture that Brazilians have of self-diagnosing have collaborated to the increase of these practices. Misinformation in the social networks about pharmacological treatments favored the shortage of pharmacies and drugstores, harming even hospital care. Drugs advertised as prophylactic and curative for the new coronavirus proved to be ineffective in vivo clinical trials applied mostly in hospitalized patients with COVID-19, except for remdesivir and dexamethasone, which contributed significantly in the treatment of moderate to severe cases. Pharmaceutical professionals were important in raising public awareness about the adverse effects of drugs, fighting fake news, and producing vaccines. It was also possible to observe the lack of resources that Brazilian universities have to generate science, making financial support necessary to enable research into new drugs and vaccine manufacturing.
References
Airagnes, G., Pelissolo, A., Lavallée, M., Flament, M., & Limosin, F. (2016). Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management. Current Psychiatry Reports, 18(10), 89. https://doi.org/10.1007/s11920-016-0727-9
AMIB, Associação de Medicina Intensiva Brasileira. (2021). Orientações sobre o manejo de medicamentos analgésicos, sedativos e bloqueadores neuromusculares para intubação traqueal, manutenção de pacientes em ventilação mecânica e anestesia em situações de escassez no contexto da pandemia Covid-19. Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde, 16-35. http://www.sbrafh.org.br/inicial/wp-content/uploads/2021/03/Orienta%C3%A7%C3%B5es-sobre-manejo-de-medicamentos-no-contexto-da-pandemia-COVID-19_210321.pdf
ANVISA, Agência Nacional de Vigilância Sanitária. (2001). Consulta Pública nº 95, de 19 de novembro, de 2001. http://www4.anvisa.gov.br/base/visadoc/CP/CP%5B2735-1-0%5D.PDF
Aquino, E. M. L., Silveira, I. H., Pescarini, J. M., Aquino, R., & de Souza-Filho, J. A. (2020). Social distancing measures to control the COVID-19 pandemic: Potential impacts and challenges in Brazil. Ciência e Saúde Coletiva, 25(1), 2423–2446. https://doi.org/10.1590/1413-81232020256.1.10502020
Arrais, P. S. D., Fernandes, M. E. P., Pizzol, T. da S. D., Ramos, L. R., Mengue, S. S., Luiza, V. L., Tavares, N. U. L., Farias, M. R., Oliveira, M. A., & Bertoldi, A. D. (2016). Prevalence of self-medication in Brazil and associated factors. Revista de Saúde Pública, 50(2), 1–11. https://doi.org/10.1590/S1518-8787.2016050006117
Barros, G. A. M. de, Calonego, M. A. M., Mendes, R. F., Castro, R. A. M., Faria, J. F. G., Trivellato, S. A., Cavalcante, R. S., Fukushima, F. B., & Dias, A. (2019). The use of analgesics and risk of self-medication in an urban population sample: cross-sectional study. Brazilian Journal of Anesthesiology (English Edition), 69(6), 529–536. https://doi.org/10.1016/j.bjane.2019.10.006
Barros, M. B. de A., Lima, M. G., Malta, D. C., Szwarcwald, C. L., Azevedo, R. C. S. de, Romero, D., Souza Júnior, P. R. B. de, Azevedo, L. O., Machado, Í. E., Damacena, G. N., Gomes, C. S., Werneck, A. de O., Silva, D. R. P., Pina, M. de F. de, & Gracie, R. (2020). Relato de tristeza/depressão, nervosismo/ansiedade e problemas de sono na população adulta brasileira durante a pandemia de COVID-19. Epidemiologia e Serviços de Saúde: Revista do Sistema Unico de Saude do Brasil, 29(4), e2020427. https://doi.org/10.1590/s1679-49742020000400018
Beckhauser, G. C., De Souza, J. M., Valgas, C., Piovezan, A. P., & Galato, D. (2010). Utilização de medicamentos na pediatria: A prática de automedicação em crianças por seus responsáveis. Revista Paulista de Pediatria, 28(3), 262–268. https://doi.org/10.1590/S0103-05822010000300002
Ministério da Saúde. (2020). Sobre a doença. COVID-19. https://coronavirus.saude.gov.br/sobre-a-doenca#
Cavalcanti, A. B., Zampieri, F. G., Rosa, R. G., Azevedo, L. C. P., Veiga, V. C., Avezum, A., Damiani, L. P., Marcadenti, A., Kawano-Dourado, L., Lisboa, T., Junqueira, D. L. M., de Barros e Silva, P. G. M., Tramujas, L., Abreu-Silva, E. O., Laranjeira, L. N., Soares, A. T., Echenique, L. S., Pereira, A. J., Freitas, F. G. R., & Berwanger, O. (2020). Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. New England Journal of Medicine, 383(21), 2041–2052. https://doi.org/10.1056/nejmoa2019014
Ceron, W., de-Lima-Santos, M. F., & Quiles, M. G. (2021). Fake news agenda in the era of COVID-19: Identifying trends through fact-checking content. Online Social Networks and Media, 21, 100116. https://doi.org/10.1016/j.osnem.2020.100116
Cespedes, M. S., & Souza, J. C. R. (2020). Sars-CoV-2: A clinical update - II. Revista da Associação Médica Brasileira, 66(4), 547–557. https://doi.org/10.1590/1806-9282.66.4.547
CFF, Conselho Federal de Farmácia. (2019a). Pesquisa sobre uso racional de medicamentos. http://www.cff.org.br/noticia.phpid=5279&titulo=Veja+a+repercussão+da+pesquisa+sobre+uso+racional+de+medicamentos+na+mídia
CFF, Conselho Federal de Farmácia. (2019b). Uso de Medicamentos. Datafolha Instituto de Pesquisa. https://www.cff.org.br/userfiles/file/Uso de Medicamentos - Relatório _final.pdf
CFF, Conselho Federal de Farmácia. (2020a). Levantamento mostra como o medo da Covid-19 impactou venda de medicamentos. https://www.cff.org.br/noticia.php?id=5747
CFF, Conselho Federal de Farmácia. (2020b). Venda de medicamentos psiquiátricos cresce na pandemia. http://covid19.cff.org.br/venda-de-medicamentos-psiquiatricos-cresce-na-pandemia/
CFF, Conselho Federal de Farmácia. (2021). Venda de remédios sem eficácia comprovada contra a COVID-19 dispara. https://www.cff.org.br/noticia.php?id=6197&titulo=Venda+de+remédios+sem+eficácia+comprovada+contra+a+Covid+dispara
Choo, E. K., & Rajkumar, S. V. (2020). Medication Shortages During the COVID-19 Crisis: What We Must Do. Mayo Clinic Proceedings, 95(6), 1112–1115. https://doi.org/10.1016/j.mayocp.2020.04.001
CLINICALTRIALS. (2020). Várias combinações de Inibidores de Protease, Oseltamivir, Favipiravir e Cloroquina para o Tratamento de COVID-19: Um Estudo de Controle Randomizado (THDMS-COVID19). National Library of Medicine (EUA). https://clinicaltrials.gov/ct2/show/NCT04303299
CLINICALTRIALS. (2021). A Trial of Remdesivir in Adults With Severe COVID-19. National Library of Medicine (EUA). https://clinicaltrials.gov/ct2/show/NCT04257656
Domingues, P. H. F., Galvão, T. F., Andrade, K. R. C. de, Araújo, P. C., Silva, M. T., & Pereira, M. G. (2017). Prevalência e fatores associados à automedicação em adultos no Distrito Federal: estudo transversal de base populacional. Epidemiologia e Serviços de Saúde: Revista do Sistema Único de Saude do Brasil, 26(2), 319–330. https://doi.org/10.5123/S1679-49742017000200009
FAPESP, Fundação de Amparo à Pesquisa do Estado de São Paulo. (2019). Fake news na ciência. Retrieved Mar. 2, 2021, from https://agencia.fapesp.br/fake-newsna-ciencia/30120/
FEBRAFAR, Federação Brasileira das Redes Associativistas e Independentes de Farmácias. (2020). Ivermectina e nitazoxanida deixam de ser controlados. https://www.febrafar.com.br/ivermectina-e-nitazoxanida-deixam-controlados/
Ferreira, L. L. G., & Andricopulo, A. D. (2020). Medicamentos e tratamentos para a Covid-19. Estudos Avançados, 34(100), 7–27. https://doi.org/10.1590/s0103-4014.2020.34100.002
Galhardi, C. P., Freire, N. P., Minayo, M. C. de S., & Fagundes, M. C. M. (2020). Fact or fake? An analysis of disinformation regarding the covid-19 pandemic in Brazil. Ciência e Saúde Coletiva, 25, 4201–4210. https://doi.org/10.1590/1413-812320202510.2.28922020
Gama, A. S. M., & Secoli, S. R. (2020). Self-medication practices in riverside communities in the Brazilian Amazon Rainforest. Revista Brasileira de Enfermagem, 73(5), e20190432. https://doi.org/10.1590/0034-7167-2019-0432
Goff, D. A., Ashiru-Oredope, D., Cairns, K. A., Eljaaly, K., Gauthier, T. P., Langford, B. J., Mahmoud, S. F., Messina, A. P., Michael, U. C., Saad, T., & Schellack, N. (2020). Global contributions of pharmacists during the COVID-19 pandemic. JACCP Journal of the American College of Clinical Pharmacy, 3(8), 1480–1492. https://doi.org/10.1002/jac5.1329
Goldman, J. D., Lye, D. C. B., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., Spinner, C. D., Galli, M., Ahn, M.-Y., Nahass, R. G., Chen, Y.-S., SenGupta, D., Hyland, R. H., Osinusi, A. O., Cao, H., Blair, C., Wei, X., Gaggar, A., Brainard, D. M., & Subramanian, A. (2020). Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. New England Journal of Medicine, 383(19), 1827–1837. https://doi.org/10.1056/nejmoa2015301
Gras, M., Gras-Champel, V., Moragny, J., Delaunay, P., Laugier, D., Masmoudi, K., & Liabeuf, S. (2021). Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication. Annales Pharmaceutiques Francaises, 79(5), 522-529. https://doi.org/10.1016/j.pharma.2021.02.003
Group, R. C., Horby, P., Lim, W. S., Emberson, J. R., Mafham, M., Bell, J. L., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., Prudon, B., Green, C., Felton, T., Chadwick, D., Rege, K., Fegan, C., Chappell, L. C., & Fa, M. J. (2021). Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine, 384(8), 693–704. https://doi.org/10.1056/nejmoa2021436
Hung, I. F. N., Lung, K. C., Tso, E. Y. K., Liu, R., Chung, T. W. H., Chu, M. Y., Ng, Y. Y., Lo, J., Chan, J., Tam, A. R., Shum, H. P., Chan, V., Wu, A. K. L., Sin, K. M., Leung, W. S., Law, W. L., Lung, D. C., Sin, S., Yeung, P., & Yuen, K. Y. (2020). Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. The Lancet, 395(10238), 1695–1704. https://doi.org/10.1016/S0140-6736(20)31042-4
ICTQ, Instituto de Ciência, Tecnologia e Qualidade. (2014). Automedicação no Brasil. https://www.ictq.com.br/pesquisa-do-ictq/353-indicacaode-amigo-reforca-a-pratica-da-automedicacao
ICTQ, Instituto de Ciência, Tecnologia e Qualidade. (2018). Automedicação no Brasil. https://www.ictq.com.br/pesquisa-do-ictq/871-pesquisa-automedicacao-no-brasil-2018
ICTQ, Instituto de Ciência, Tecnologia e Qualidade. (2020). Covid-19: Interações Medicamentosas nas Terapias Experimentais. https://www.ictq.com.br/opiniao/1376-covid-19-interacoes-medicamentosas-nas-terapiasexperimentais
ICTQ, Instituto de Ciência, Tecnologia e Qualidade. (2021). O protagonismo do farmacêutico na mídia em tempos de pandemia. https://www.ictq.com.br/marketing-farmaceutico/1456-o-protagonismo-do-farmaceutico-na-midia-em-tempos-de-pandemia-2#
Ingelbeen, B., Koirala, K. D., Verdonck, K., Barbé, B., Mukendi, D., Thong, P., El Safi, S., Van Duffel, L., Bottieau, E., van der Sande, M. A. B., Boelaert, M., Chappuis, F., & Jacobs, J. (2020). Antibiotic use prior to seeking medical care in patients with persistent fever: a cross-sectional study in four low- and middle-income countries. Clinical Microbiology and Infection, https://doi.org/10.1016/j.cmi.2020.11.003
Joshi, S., Parkar, J., Ansari, A., Vora, A., Talwar, D., Tiwaskar, M., Patil, S., & Barkate, H. (2021). Role of favipiravir in the treatment of COVID-19. International Journal of Infectious Diseases, 102, 501–508. https://doi.org/10.1016/j.ijid.2020.10.069
Khuroo, M. S. (2020). Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal. International Journal of Antimicrobial Agents, 56(3), 106101. https://doi.org/10.1016/j.ijantimicag.2020.106101
Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
Lee, N., Allen Chan, K. C., Hui, D. S., Ng, E. K. O., Wu, A., Chiu, R. W. K., Wong, V. W. S., Chan, P. K. S., Wong, K. T., Wong, E., Cockram, C. S., Tam, J. S., Sung, J. J. Y., & Lo, Y. M. D. (2004). Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. Journal of Clinical Virology, 31(4), 304–309. https://doi.org/10.1016/j.jcv.2004.07.006
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery, 6(1), 6–9. https://doi.org/10.1038/s41421-020-0156-0
Makowska, M., Boguszewski, R., Nowakowski, M., & Podkowińska, M. (2020). Self-Medication-Related Behaviors and Poland’s COVID-19 Lockdown. International Journal of Environmental Research and Public Health, 17(22), 8344. https://www.ncbi.nlm.nih.gov/pmc/article s/PMC7696561/%0Ahttps://www.mdpi.com/1660-4601/17/22/8344
Matos, R. C. de. (2020). Fake news frente a pandemia de COVID-19. Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia, 8(3), 78–85. https://doi.org/10.22239/2317-269x.01595
McFee, R. B. (2020). COVID-19: Therapeutics and interventions currently under consideration. Disease-a-Month, 66(9), 101058. https://doi.org/10.1016/j.disamonth.2020.101058
Miñan, T. A., Conde, E. A., Calderon, A. D., Cáceres, O. D., Peña, R. A. J., & Donoso, R. C. R. (2020). Factores asociados a la automedicación con fármacos relacionados a COVID-19 en estudiantes de ciencias de la salud de una ciudad peruana. Scielo, 22. https://doi.org/10.1590/SciELOPreprints.1225
Monteiro, F. F. C., Araújo, I. G., Santos, R. O., Nascimento, R. M., Loureiro, L. M. A., Pessoa, E. T. F. P., & Morais, A. C. L. N. (2020). O papel da assistência farmacêutica no tratamento de pacientes com COVID-19 em hospital de referência no município de Fortaleza. Revista de Casos e Consultoria, 11(1), e11127. https://periodicos.ufrn.br/casoseconsultoria/article/view/22498
Moreira, T. de A., Alvares-Teodoro, J., Barbosa, M. M., Júnior, A. A. G., & Acurcio, F. de A. (2020). Use of medicines by adults in primary care: Survey on health services in Minas Gerais, Brazil. Revista Brasileira de Epidemiologia, 23. https://doi.org/10.1590/1980-549720200025
Nasir, M., Abu, K., Salauddin, A., Zahan, T., & Ara, R. (2020). Prevalencia, patrón e impacto de la automedicación de agentes antiinfecciosos durante el brote de COVID-19 en la ciudad de Dhaka. Journal of Chemical Information and Modeling, 53(9), 1689–1699
Naves, J. de O. S., Castro, L. L. C. de, Carvalho, C. M. S. de, & Merchán-Hamann, E. (2010). Automedicação: uma abordagem qualitativa de suas motivações. Ciência & Saúde Coletiva, 15(1), 1751–1762. https://doi.org/10.1590/s1413-81232010000700087
Oliveira, A. C. de C. L., Magalhães, N. C. V., Silva, P. A. A. A., Barja, P. R., & Viriato, A. (2021). Gestão Hospitalar De Equipamentos De Proteção Individual No Enfrentamento À Pandemia Covid19 / Hospital Management of Personal Protection Equipment in Addressing the Pandemic Covid19. Brazilian Journal of Development, 7(3), 23814–23831. https://doi.org/10.34117/bjdv7n3-203
Onchonga, D. (2020). A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharmaceutical Journal, 28(7), 903–904. https://doi.org/10.1016/j.jsps.2020.06.007
UO, University of Oxford. (2021). Randomised Evaluation of COVID-19 Therapy (RECOVERY). U.S. National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04381936
Paiva, B. A. M., Pinto, A. W. S., Cançado, B. L., Chequer, F. M. D., & Pereira, M. L. (2020). Efeitos das “promessas terapêuticas” sobre os preços de medicamentos em tempos de pandemia. Journal of Health and Biological Sciences, 8(1). https://periodicos.unichristus.edu.br/jhbs/article/view/3407
Paiva, B. A. M., Pinto, A. W. S., Santos, W., Rocha, R., & Júnior, J. E. S. (2020). After COVID-19: Building Purpose through Stakeholders in Retailing. 13° Congresso Latino-Americano de Varejo e Consumo. https://cev.fgv.br/eventos/13o-congresso-latino-americano-de-varejo-e-consumo-after-covid-19-building-purpose-through
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372(71). https://doi.org/10.1136/bmj.n71
Pan, H., Peto, R., Restrepo, A. M. H., Preziosi, M. P., Sathiyamoorthy, V., Karim, Q. A., Lejandria, M. M., García, C. H., Kieny, M. P., Malekzadeh, R., Murthy, S., Reddy, K. S., Periago, M. R., Hanna, P. A., Ader, F., Bader, A. M. A., Alhasawi, A., & Allum, S. (2021). Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results. New England Journal of Medicine, 384(6), 497–511. https://doi.org/10.1056/NEJMoa2023184
Pereira, A. S., et al. (2018). Metodologia da pesquisa científica.
Pons, E. D. S., Knauth, D. R., Vigo, Á., Mengue, S. S., Gadelha, C. A. G., Costa, K. S., Do Nascimento, J. M., Soeiro, O. M., Mengue, S. S., Da Motta, M. L., & De Carvalho, A. C. C. (2017). Predisposing factors to the practice of self-medication in Brazil: Results from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM). PLoS ONE, 12(12), 1–12. https://doi.org/10.1371/journal.pone.0189098
Rahmawati, R., & Bajorek, B. V. (2017). Self-medication among people living with hypertension: A review. Family Practice, 34(2), 147–153. https://doi.org/10.1093/fampra/cmw137
RML, Rocky Mountain Laboratories. (2021). COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. from https://www.covid19treatmentguidelines.nih.gov/
Salama, C., Han, J., Yau, L., Reiss, W. G., Kramer, B., Neidhart, J. D., Criner, G. J., Kaplan-Lewis, E., Baden, R., Pandit, L., Cameron, M. L., Garcia-Diaz, J., Chávez, V., Mekebeb-Reuter, M., Lima de Menezes, F., Shah, R., González-Lara, M. F., Assman, B., Freedman, J., & Mohan, S. V. (2021). Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. New England Journal of Medicine, 384(1), 20–30. https://doi.org/10.1056/nejmoa2030340
Santos, C. M.; Costa, P., Cibele A. de M., & Nobre, M. R. C. (2007). A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Revista Latino-Americana de Enfermagem, 15(3), 508-511. https://doi.org/10.1590/S0104-11692007000300023
Santana, R. M., & Honório, J. E. R. (2016). Os cuidados do farmacêutico com a imunização. Revista Baiana de Saúde Pública, 1(1), 442-456.
SBEM, Sociedade Brasileira de Endocrinologia e Metabologia. (2020). Comunicado da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) sobre os riscos do uso indiscriminado e da automedicação com Dexametasona. https://www.endocrino.org.br/sbem-alerta-sobre-uso-da-dexametasona/
Silva, M. E. H., & Abreu, C. R. C. (2021). Medicamentos Off-Label. Revista JRG de Estudos Acadêmicos, 4(8), 300–308.
Sousa, A. R. de, Alencar, D. de C., Silva, Á. M. M. da, Souza, C. S. de, Barros, J. F., & Pereira, Á. (2019). Homens, necessidades de saúde e motivações para a automedicação. Cultura de Los Cuidados, 23(55), 126. https://doi.org/10.14198/cuid.2019.55.12
Spinner, C. D., Gottlieb, R. L., Criner, G. J., Arribas López, J. R., Cattelan, A. M., Soriano Viladomiu, A., Ogbuagu, O., Malhotra, P., Mullane, K. M., Castagna, A., Chai, L. Y. A., Roestenberg, M., Tsang, O. T. Y., Bernasconi, E., Le Turnier, P., Chang, S. C., Sengupta, D., Hyland, R. H., Osinusi, A. O., & Marty, F. M. (2020). Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19: A Randomized Clinical Trial. JAMA - Journal of the American Medical Association, 324(11), 1048–1057. https://doi.org/10.1001/jama.2020.16349
Stone, J. H., Frigault, M. J., Serling-Boyd, N. J., Fernandes, A. D., Harvey, L., Foulkes, A. S., Horick, N. K., Healy, B. C., Shah, R., Bensaci, A. M., Woolley, A. E., Nikiforow, S., Lin, N., Sagar, M., Schrager, H., Huckins, D. S., Axelrod, M., Pincus, M. D., Fleisher, J., & Mansour, M. K. (2020). Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. New England Journal of Medicine, 383(24), 2333–2344. https://doi.org/10.1056/nejmoa2028836
Sun, J., Deng, X., Chen, X., Huang, J., Huang, S., Li, Y., Feng, J., Liu, J., & He, G. (2020). Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System. Clinical Pharmacology and Therapeutics, 108(4), 791–797. https://doi.org/10.1002/cpt.1866
TRENDS, GOOGLE TRENDS. (2020). Automedicação no Brasil. https://trends.google.com.br/trends/explore?q=automedicação&geo=BR
Truta, C. N., Maurício, V. A. S., Magalhães, F. C., Silva, G. F., Fernandes, G. V., Queiroz, R. M. L., Uchoa, S. A. C., & Martiniano, C. S. (2017). Prevalência e Características da Automedicação entre os Idosos: Revisão Bibliográfica. XV Encontro Latino Americano de Iniciação Científica e XI Encontro Latino Americano de Pós-Graduação Universidade do Vale da Paraíba, 9(5), 23–47.
Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine and International Health, 25(3), 278–280. https://doi.org/10.1111/tmi.13383
WHO, World Health Organization. (2000). Guidelines for the regulatory assessment of medicinal products for use in self-medication. https://apps.who.int/iris/handle/10665/66154.
WHO, World Health Organization. (2020a). Director-General’s opening remarks at the media briefing on COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
WHO, World Health Organization. (2020b). Director-General’s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19---11-march-2020.
Zhang, A., Hobman, E. V., De Barro, P., Young, A., Carter, D. J., & Byrne, M. (2021). Self-medication with antibiotics for protection against COVID-19: The role of psychological distress, knowledge of, and experiences with antibiotics. Antibiotics, 10(3), 1–14. https://doi.org/10.3390/antibiotics10030232
Zhou, P., Yang, X. Lou, Wang, X. G., Hu, B., Zhang, L., Zhang, W., Si, H. R., Zhu, Y., Li, B., Huang, C. L., Chen, H. D., Chen, J., Luo, Y., Guo, H., Jiang, R. Di, Liu, M. Q., Chen, Y., Shen, X. R., Wang, X., & Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Larissa Aparecida dos Santos Martins Oliveira; Andreza Martins de Souza; Vanessa Medeiros Custódio; Juliana Souza Dionísio dos Santos; Luana dos Santos Castro; Daniel Teles Zatta; Rodrigo Luís Taminato; Fernando Yano Abrão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
